Effect of Foot-ankle Exercise Using Elastic Band

November 13, 2025 updated by: Maria Suryani, St Elisabeth School Health Science

Effect of Foot-ankle Exercise Using Elastic Band on Diabetic Foot Ulcer Incidence in Patient With Diabetes Neuropathy

The goal of this clinical trial is to learn if foot-ankle exercise can prevent diabetic foot ulcer incidence in patient with diabetes neuropathy. It will also learn about the effect of foot-ankle exercise on improvement of diabetes neuropathy severity, glycemic control, brain-derived neurotropic factor, walking speed, foot ankle range of motion, callus. The main questions it aims to answer are:

  • Does foot-ankle exercise lower the number of diabetic ulcer incidence
  • Does foot-ankle exercise lower the diabetes neuropathy severity
  • Does foot-ankle exercise improve glycemic control
  • Does foot-ankle exercise improve brain-derived neurotrophic factor
  • Does foot-ankle exercise improve walking speed
  • Does foot-ankle exercise improve foot ankle range of motion
  • Does foot-ankle exercise lower the number of callus incidence

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Researchers will compare intervention group foot-ankle exercise used elastic band to a control group to see if foot-ankle exercise work to prevent diabetic foot ulcer incidence in patient with diabetes neuropathy

Participants will:

  • Do foot-ankle exercise for three times a week with non-consecutive day for 1 year
  • Report the incidence of callus and diabetic foot ulcer whenever they have

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Central Java
      • Semarang, Central Java, Indonesia, 50231
        • Elisabeth clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • type 2 diabetes
  • can walk minimal 10 meters
  • neuropathy diabetic

Exclusion Criteria:

  • stroke
  • active ulcer
  • fracture on foot area
  • diabetic ulcer history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: foot-ankle exercise group
The group will receive usual care with additional food-ankle exercises using elastic band supervised by professional health care three times a week for twelve weeks. After twelve weeks period the patient will continue exercising for the completion of the study (9 month) by them self with the help of foot-ankle exercise video.
The exercise was done 3 times a week (15x/until they tired x 2set). The exercise used a elastic band with difference thickness (0,5 mm in 12 weeks and 0,65 mm in nine month)
No Intervention: control group
Patient will receive usual care, with include pharmacological treatment and self care guidelines, which are maintained in both group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diabetic foot ulcer (DFU) incidence
Time Frame: for a year
DFU, defined as a wound in the area below the ankle that reaches at least the epidermis and part of the dermis, as diagnosed by an internist
for a year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diabetic neuropathy examination score
Time Frame: 0, 12 weeks, and a year
The accumulation score of the result measurement consists of eight item, two testing muscle strength, one a tendon reflex, and five sensation. The min-max score is 0-16. The higher the score indicates the more severe the neuropathy. The score was determined by doing a physical examination.
0, 12 weeks, and a year
control glyacemic
Time Frame: 0, 12 weeks, and a year
HbA1c levels, which are the level of blood sugar control over a period of time. 3 months, measured by analyzing blood serum in a laboratory using the National Glycohemoglobin Standardization Program (NGSP).
0, 12 weeks, and a year
brain derived neurotrophic factor
Time Frame: 0, 12 weeks, and a year
BDNF levels, which are defined as biomolecular markers that can indicate the severity of diabetic neuropathy, as measured by analyzing blood serum using the ELIZA technique
0, 12 weeks, and a year
walking speed
Time Frame: 0, 12 weeks, and a year
Walking speed is the ratio between times measured while walking in second as fast as possible on a flat and flat trajectory at a certain distance. A track distance used in the study was 5 meter. The time of waking was measured using stopwatch
0, 12 weeks, and a year
foot ankle range of motion
Time Frame: 0, 12 weeks, and a year
ankle range of motion, which is the degree of joint movement in the feet during flexion, extension, inversion, and eversion, as measured using digital goniometry
0, 12 weeks, and a year
callus insidence
Time Frame: 0, 12 weeks, and a year
Callus is the thickness of the plantar skin area that can be determined by inspection
0, 12 weeks, and a year
neuropathy symptom score
Time Frame: 0, 12 weeks, and a year
The accumulation score of the result measurement consists of sixteen item about the symptom of neuropathy. The min-max score is 0-16. The more score indicates the more severe of neuropathy. The score was determined by interviewing the patient
0, 12 weeks, and a year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: maria suryani, stikes elisabeth

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

September 22, 2025

First Submitted That Met QC Criteria

November 13, 2025

First Posted (Actual)

November 17, 2025

Study Record Updates

Last Update Posted (Actual)

November 17, 2025

Last Update Submitted That Met QC Criteria

November 13, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetic Foot Ulcer (DFU)

Clinical Trials on foot-ankle exercise

Subscribe